SEC ownership of SpyGlass Pharma, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001778922.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

50/50

Latest evidence

30 Jun 2026

Top shareholders Insider holders Latest transactions
Public ticker
SGP on Nasdaq
Parsed ownership sources
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder
RA CAPITAL MANAGEMENT, L.P.
Ranking: Comparable ownership first, then disclosed value
Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
RA CAPITAL MANAGEMENT, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001778922
Issuer location
Irvine, CA

Ownership snapshot

Top shareholders of SpyGlass Pharma, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 24% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-8 of 50 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 24%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 24%
New Enterprise Associates 17, L.P. 22%
Vensana Capital I GP, LLC 9.9%
Sands Capital Life Sciences Pulse... 7.8%
Gilde Healthcare Holding B.V. 6.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G 3/4/5
Company · Director, 10%+ Owner
13F 13D/G 3/4/5
24%
from 13D/G
$178,550,064
8,021,117 shares
 — 30 Jun 2026
New Enterprise Associates 17, L.P.
3/4/5 13D/G
10%+ Owner · Ali Behbahani
3/4/5 13D/G
22%
from 13D/G
$167,955,108
6,035,038 shares
 — 09 Feb 2026
Vensana Capital I GP, LLC
3/4/5 13D/G
10%+ Owner · Kirk Nielsen
3/4/5 13D/G
9.9%
from 13D/G
—
3,310,619 shares
 — 09 Feb 2026
Sands Capital Life Sciences Pulse Fund III (DE), L.P.
13D/G
SANDS FRANK M.
13D/G
7.8%
—
2,500,012 shares
 $0 06 Feb 2026
Gilde Healthcare Holding B.V.
13D/G
13D/G
6.6%
—
2,187,513 shares
 $0 09 Feb 2026
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
13D/G
6.3%
—
2,109,953 shares
 $0 09 Feb 2026
Mathers Edward T.
3/4/5
10%+ Owner
3/4/5
18%
$167,955,108
6,035,038 shares
 — 09 Feb 2026
Rick Yang
3/4/5
10%+ Owner
3/4/5
18%
$167,955,108
6,035,038 shares
 — 09 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 24 reporting-owner rows connected to SpyGlass Pharma, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
24
Largest Forms 3/4/5 holder
Rick Yang
Net 12M change
$0
Latest report
09 Feb 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Rick Yang 10%+ Owner $167,955,108 Mixed 09 Feb 2026
Mathers Edward T. 10%+ Owner $167,955,108 Mixed 09 Feb 2026
New Enterprise Associates 17, L.P. 10%+ Owner $167,955,108 Mixed 09 Feb 2026
Kirk G. Nielsen Director $92,134,527 Mixed 09 Feb 2026
Geoffrey B. Pardo Director $60,878,487 Mixed 09 Feb 2026
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $57,181,689 Mixed 09 Feb 2026
Scott D. Sandell 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Forest Baskett 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Paul Edward Walker 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Ali Behbahani Director, 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Carmen Chang 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Mohamad Makhzoumi 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Anthony A. Florence Jr. 10%+ Owner $37,772,629 Mixed 09 Feb 2026
Bilal Arshad Khan Director $7,705,487 Mixed 09 Feb 2026
Malik Y. Kahook President, Chief Medical Officer, Executive Chair, Director Mixed 05 Feb 2026
Chetan Pratap Pujara Chief R&D Officer Mixed 05 Feb 2026
James Robert Dennewill Jr. Chief Operating Officer Mixed 05 Feb 2026
Zachary Scheiner Director Mixed 05 Feb 2026
Michael Dybbs Director Mixed 05 Feb 2026
Vensana Capital I GP, LLC 10%+ Owner Mixed 09 Feb 2026

Recent insider transactions for SpyGlass Pharma, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Ra Capital Management, L.P. SGP Common Stock Purchase 162.1% 3,690,000 5,966,439 09 Feb 2026 See footnotes
Ra Capital Management, L.P. SGP Common Stock Conversion of derivative security 4,331,117 2,524,473 09 Feb 2026 See footnotes
Ra Capital Management, L.P. SGP Series D Preferred Stock Conversion of derivative security -100% -494,647 0 09 Feb 2026 See footnotes
Ra Capital Management, L.P. SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,918,235 0 09 Feb 2026 See footnotes
Ra Capital Management, L.P. SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,918,235 0 09 Feb 2026 See footnotes
Kirk G. Nielsen SGP Series D Preferred Stock Conversion of derivative security -100% -359,255 0 09 Feb 2026 See Footnote
Kirk G. Nielsen SGP Series C-2 Preferred Stock Conversion of derivative security -100% -548,067 0 09 Feb 2026 See Footnote
Kirk G. Nielsen SGP Series C-1 Preferred Stock Conversion of derivative security -100% -548,067 0 09 Feb 2026 See footnote
Kirk G. Nielsen SGP Series B Preferred Stock Conversion of derivative security -100% -1,690,230 0 09 Feb 2026 See footnote
Ali Behbahani SGP Common Stock Conversion of derivative security 1,357,263 1,357,263 09 Feb 2026 See Note 3
Ali Behbahani SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 See Note 2
Ali Behbahani SGP Common Stock Conversion of derivative security 5,097,538 5,097,538 09 Feb 2026 See Note 2
Ali Behbahani SGP Series B Preferred Stock Conversion of derivative security -100% -402,273 0 09 Feb 2026 See Note 3
Ali Behbahani SGP Series A Preferred Stock Conversion of derivative security -100% -954,990 0 09 Feb 2026 See Note 3
Ali Behbahani SGP Series D Preferred Stock Conversion of derivative security -100% -737,962 0 09 Feb 2026 See Note 2
Ali Behbahani SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Ali Behbahani SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Ali Behbahani SGP Series B Preferred Stock Conversion of derivative security -100% -1,619,240 0 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Common Stock Conversion of derivative security 1,357,263 1,357,263 09 Feb 2026 See Note 3
Anthony A. Florence Jr. SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Common Stock Conversion of derivative security 5,097,538 5,097,538 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Series B Preferred Stock Conversion of derivative security -100% -402,273 0 09 Feb 2026 See Note 3
Anthony A. Florence Jr. SGP Series A Preferred Stock Conversion of derivative security -100% -954,990 0 09 Feb 2026 See Note 3
Anthony A. Florence Jr. SGP Series D Preferred Stock Conversion of derivative security -100% -737,962 0 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Anthony A. Florence Jr. SGP Series B Preferred Stock Conversion of derivative security -100% -1,619,240 0 09 Feb 2026 See Note 2
Forest Baskett SGP Common Stock Conversion of derivative security 1,357,263 1,357,263 09 Feb 2026 See Note 3
Forest Baskett SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 See Note 2
Forest Baskett SGP Common Stock Conversion of derivative security 5,097,538 5,097,538 09 Feb 2026 See Note 2
Forest Baskett SGP Series B Preferred Stock Conversion of derivative security -100% -402,273 0 09 Feb 2026 See Note 3
Forest Baskett SGP Series A Preferred Stock Conversion of derivative security -100% -954,990 0 09 Feb 2026 See Note 3
Forest Baskett SGP Series D Preferred Stock Conversion of derivative security -100% -737,962 0 09 Feb 2026 See Note 2
Forest Baskett SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Forest Baskett SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Forest Baskett SGP Series B Preferred Stock Conversion of derivative security -100% -1,619,240 0 09 Feb 2026 See Note 2
New Enterprise Associates 17, L.P. SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 Direct
New Enterprise Associates 17, L.P. SGP Common Stock Conversion of derivative security 5,097,538 5,097,538 09 Feb 2026 Direct
New Enterprise Associates 17, L.P. SGP Series D Preferred Stock Conversion of derivative security -100% -737,962 0 09 Feb 2026 Direct
New Enterprise Associates 17, L.P. SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 Direct
New Enterprise Associates 17, L.P. SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 Direct
New Enterprise Associates 17, L.P. SGP Series B Preferred Stock Conversion of derivative security -100% -1,619,240 0 09 Feb 2026 Direct
Rick Yang SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 See Note 2
Rick Yang SGP Common Stock Conversion of derivative security 5,097,538 5,097,538 09 Feb 2026 See Note 2
Rick Yang SGP Series D Preferred Stock Conversion of derivative security -100% -737,962 0 09 Feb 2026 See Note 2
Rick Yang SGP Series C-2 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Rick Yang SGP Series C-1 Preferred Stock Conversion of derivative security -100% -1,370,168 0 09 Feb 2026 See Note 2
Rick Yang SGP Series B Preferred Stock Conversion of derivative security -100% -1,619,240 0 09 Feb 2026 See Note 2
Mohamad Makhzoumi SGP Common Stock Conversion of derivative security 1,357,263 1,357,263 09 Feb 2026 See Note 3
Mohamad Makhzoumi SGP Common Stock Purchase 18.4% 937,500 6,035,038 09 Feb 2026 See Note 2
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .